Noninvasive neuroimaging is an advanced medical technology that uses imaging techniques such as MRI (magnetic resonance imaging) and CT (computed tomography) to observe an individual's brain without needing to open it up to the skull. It is a fast, noninvasive, and relatively painless way to observe the internal structure and functions of the brain. This medical technology is used to diagnose various neurological conditions, such as Alzheimer's disease, Parkinson's disease, stroke, brain tumours, and traumatic brain injuries. Noninvasive neuroimaging can also provide useful information about the effects of certain conditions on the brain, such as those caused by drug or alcohol use, or environmental factors. Noninvasive neuroimaging involves a simple process whereby the patient is placed in a scanner that uses magnetic fields and radio waves to produce detailed images of the brain. This scan produces a 3-dimensional map of the various structures and functions of the brain such as the cortical lobes, white matter, grey matter, and cerebrospinal fluid, as well as any disease states or injury. This information can be used to identify any structural or functional changes that may be occurring within the brain. Noninvasive neuroimaging has many advantages including a shorter scan time, lower cost, and the ability to track changes in a patient’s brain over time without repeated surgery. This technology is also becoming increasingly sophisticated, with the use of noninvasive techniques such as functional MRI (fMRI) and positron emission tomography (PET) becoming more common in clinical practice.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom